NOXXON Pharma NV has appointed Jose Saro as chair of its newly formed scientific advisory board which will provide strategic advice on its programmes for cancer. Dr Saro currently works at AstraZeneca Plc where he leads a group investigating solid tumours. Prior to this, he was chief medical officer at Avacta Group Plc.
Noxxon announced the appointment on 1 February 2021
Copyright 2021 Evernow Publishing Ltd